Učitavanje...
Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
BACKGROUND: Emerging evidence indicates that RUNX3 is a candidate tumor suppressor in several types of human tumors, including non-small cell lung cancer (NSCLC). However, the correlation between RUNX3 hypermethylation and clinicopathological characteristics of NSCLC remains unclear. Here, we conduc...
Spremljeno u:
| Izdano u: | Drug Des Devel Ther |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4461130/ https://ncbi.nlm.nih.gov/pubmed/26082616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76358 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|